Skip to main content
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America logoLink to Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
. 2024 Apr 26;79(3):600–603. doi: 10.1093/cid/ciae230

Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit All?

Sonali D Advani 1,1,✉,3, Rebecca North 2, Nicholas A Turner 3,, Sahra Ahmadi 4, Julia Denniss 5, Adero Francis 6, Rachel Johnson 7, Anum Hasan 8, Faryal Mirza 9, Sarah Pardue 10, Meghana Rao 11, Yasmin Rosshandler 12, Helen Tang 13, Kenneth E Schmader 14, Deverick J Anderson, for the Prevention Epicenters Program, Centers for Disease Control and Prevention15
PMCID: PMC11426257  PMID: 38666412

Abstract

In a multihospital cohort study of 3392 patients, positive urinalysis parameters had poor positive predictive value for diagnosing urinary tract infection (UTI). Combined urinalysis parameters (pyuria or nitrite) performed better than pyuria alone for ruling out UTI. However, performance of all urinalysis parameters was poor in older women.

Keywords: pyuria, leukocyte esterase, nitrite, reflex urine cultures, diagnostic stewardship


The urinalysis (UA) is a popular screening test used across inpatient and outpatient clinical settings. The extensive use of UA in patients without suspicion of urinary tract infection (UTI) leads to identification of UA parameters like pyuria or presence of nitrite, which in turn triggers urine cultures, inappropriate antimicrobial use, and associated harms like Clostridioides difficile infection [1].

On recent surveys of academic and community hospitals, almost 50% of hospital laboratories used reflex urine culture approaches (also referred to as UA with reflex to culture) [2, 3]. In this approach, when specific UA parameters (eg, leukocyte esterase, white blood cells [WBC], or bacteria) are positive, alone or in combination, the specimen is automatically processed for urine culture [4]. However, performance of UA parameters in predicting UTI has not been systematically investigated or validated for different populations [5]. Additionally, many prior investigations of UA have focused on microbiological outcomes (bacteriuria), which does not confirm presence of infection [6].

Our objectives were to (1) compare the performance of different UA parameters (alone and in combination) in predicting UTI and (2) to stratify this performance based on age and sex. More importantly, the overall goal of this study was to provide guidance to clinicians and laboratories on how to interpret urinalysis in patients with suspicion for UTI [3, 7–9].

METHODS

Study Design and Setting

This retrospective cohort study was conducted across 5 study hospitals (1 academic medical center, 4 community hospitals) in 3 states (North Carolina, Virginia, Georgia). We excluded sites that did not perform microscopic urinalysis or performed reflex urine culture orders due to variability in reflex criteria and in keeping with our goal to assess patients who received urine tests based on clinical suspicion. This study was considered exempt by Duke University Health System Institutional Review Board (protocol number 00107418) and all other participating sites.

Study Population

This study included adult patients if (1) they were hospitalized or seen in the emergency department of 1 of the 5 study hospitals between 1 January 2017 and 31 December 2019, and (2) received UA and urine culture order within 24 hours of each other. Exclusion criteria included age <18 years and presence of an indwelling urinary catheter. Duplicate or repeat patient encounters were also excluded. A random number generator was used to select patient encounters from each site for chart review.

Chart Review Process

Trained abstractors (M. R., J. D., H. T., R. J., Y. R., A. F., S. A., A. H., S. P., and F. M.) collected data from selected patients into a 60-question electronic REDCap survey (Supplementary Data 1). Objective data on demographics, laboratory, and radiographic findings was abstracted from medical records. Signs and symptoms were collected from documented vitals and clinician and nursing documentation 48 hours before and after urine culture collection. A standardized data dictionary was created. Random audits of 10% of charts were conducted by the lead investigator to ensure data integrity. The lead investigator (S. D. A.) met with abstractors biweekly during the data collection period to review any discrepancies from audits and address questions about the chart review process.

Our outcome of interest was “UTI,” defined [10] as bacterial growth of >100 000 colony-forming units per milliliter (CFU/mL) in the urine of patients with any genitourinary signs or symptoms or presence of at least 2 of the following without other cause: fever, rigors, hypotension, nausea or vomiting, delirium, or new urologic obstruction or trauma causing bleeding.

Analysis

We evaluated the performance of relevant UA parameters (pyuria, nitrite, leukocyte esterase, bacteria) in predicting UTI by assessing sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV). We also combined 18 different UA criteria (Supplementary Figure 1, Supplementary Data 2) and used the area under the receiver operating characteristic curve (AUROC) to identify the 5 best-performing models. We further assessed the NPV of pyuria, leukocyte esterase, and nitrite across different groups: male versus female, and age <65 versus ≥65 years. We also performed subanalyses for (1) outcome of UTI as defined by the Infectious Diseases Society of America (IDSA), (2) growth of Escherichia coli in urine culture, and (3) clean catch collection methods.

RESULTS

During the study period, 220 531 encounters met study criteria. After using a random number generator and removing duplicates, 3392 encounters were included for analysis. Median age across the entire cohort was 67 years (interquartile range, 54–79 years), and 2021 (59.6%) patients were female. Of the 3392 patient encounters, 1427 (42.1%) urine cultures grew organisms ≥100 000 CFU/mL, 1038 (30.6%) were negative or grew normal urogenital flora, 578 (17%) grew mixed flora, and 349 (10.3%) grew 1000–99 999 CFU/mL. Of positive urine cultures, 44.1% grew Escherichia coli. Forty-one percent of urine cultures were obtained in the emergency department (only 3 met outpatient criteria), 46.3% from medical or surgical wards, and 6.8% from intensive care units.

In this cohort, 723 (21.3%) patients met criteria for UTI. No single UA parameter had high sensitivity (≥95%) for UTI. Even though trace leukocyte esterase and low-level pyuria (≥5 white blood cells/high-power field [WBCs/hpf]) had reasonable sensitivity (90% for both), this sensitivity decreased with increasing levels of pyuria and leukocyte esterase. When examining UA parameters for their NPV, absence of trace leukocyte esterase and pyuria (≥5 WBCs/hpf) had a high NPV (95%; Table 1) for UTI. Subanalyses for IDSA definition of UTI and clean collection methods show similar results with slightly higher NPV (Supplementary Data 3). However, NPV of pyuria, leukocyte esterase, and nitrite differed based by age and sex, with poor utility in older women (Table 2).

Table 1.

Performance of Individual Urinalysis Parameters in Predicting Urinary Tract Infection (N = 3392)

Parameter Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
Leukocyte esterase (n = 3346)
 ≥Trace LE 0.90 (.88–.93) 0.49 (.47–.51) 0.33 (.31–.35) 0.95 (.94–.96)
 ≥1+ LE 0.88 (.86–.91) 0.50 (.48–.52) 0.33 (.30–.35) 0.94 (.93–.95)
 ≥2+ LE 0.21 (.18–.24) 0.80 (.79–.82) 0.23 (.20–.26) 0.79 (.77–.80)
Pyuria WBCs/hpf (n = 3230)
 ≥5 0.92 (.90–.94) 0.43 (.42–.45) 0.32 (.30–.34) 0.95 (.94–.96)
 ≥10 0.84 (.81–.86) 0.55 (.54–.57) 0.35 (.33–.37) 0.92 (.91–.94)
 ≥20 0.70 (.67–.74) 0.66 (.65–.68) 0.37 (.35–.40) 0.89 (.87–.90)
Nitrite (n = 3384)
 Positive 0.48 (.45–.52) 0.83 (.82–.84) 0.43 (.40–.47) 0.86 (.84–.87)
Bacterial count/hpf (n = 3249)
 5–50 0.20 (.18–.23) 0.77 (.75–.79) 0.20 (.17–.23) 0.77 (.76–.79)
 >50 0.72 (.69–.75) 0.71 (.69–.73) 0.41 (.39–.44) 0.90 (.89–.91)

Abbreviations: CI, confidence interval; hpf, high-power field; LE, leukocyte esterase; NPV, negative predictive value; PPV, positive predictive value; WBC, white blood cell.

Table 2.

Single-Parameter Negative Predictive Values With 95% Confidence Intervals by Age and Sex

Sex and Age Group NPV (95% CI)
≥ Trace LE ≥1+ LE ≥5 WBCs/hpf ≥10 WBCs/hpf Nitrite Positive
Female <65 y (n = 872) 0.93 (.90–.96) 0.92 (.89–.95) 0.91 (.88–.95) 0.90 (.86–.93) 0.84 (.81–.87)
Female ≥65 y (n = 1149) 0.90 (.87–.94) 0.89 (.85–.92) 0.92 (.89–.95) 0.87 (.84–.90) 0.81 (.78–.84)
Male <65 y (n = 604) 0.98 (.97–1.00) 0.98 (.97–1.00) 0.97 (.95–.99) 0.97 (.95–.98) 0.92 (.90–.95)
Male ≥65 y (n = 767) 0.98 (.96–.99) 0.97 (.96–.99) 1.00 (.99–1.00) 0.98 (.96–.99) 0.88 (.85–.90)

Abbreviations: CI, confidence interval; hpf, high-power field; LE, leukocyte esterase; NPV, negative predictive value; WBC, white blood cell.

The models using combined UA parameters (model 5 [pyuria 10 WBCs/hpf or nitrite] or model 2 [1+ leukocyte esterase or nitrite]) performed better in ruling out UTI compared to pyuria alone (Table 3). If either of these models were used as cut-offs for ordering urine cultures, 1244 (46.6%) and 1272 (47.6%) urine cultures, respectively, would have been avoided in patients without UTI, and <5% would have been missed in patients with suspicion for UTI (majority in older women).

Table 3.

Complete Performance Estimates for the 5 Models With the Best Area Under the Receiver Operating Characteristic Curve Performance

Model Test Rule AUROC NPV (95% CI)
Model 6 (n = 3231) ≥20 WBCs/hpf or nitrite 0.7093 0.92 (.91–.94)
Model 1 (n = 3347) ≥Trace LE or nitrite 0.7069 0.97 (.96–.98)
Model 5 (n = 3231) ≥10 WBCs/hpf or nitrite 0.7061 0.95 (.94–.96)
Model 2 (n = 3347) ≥1+ LE or nitrite 0.7039 0.96 (.95–.97)
Model 9 (n = 3207) ≥2+ LE or ≥20 WBCs/hpf or nitrite 0.6866 0.95 (.93–.96)
Single parameters ≥Trace LE 0.6987 0.94 (.93–.95)
≥1+ LE 0.6918 0.95 (.94–.96)
≥5 WBCs/hpf 0.6768 0.95 (.94–.96)
≥10 WBCs/hpf 0.6962 0.92 (.91–.94)
Nitrite positive 0.6565 0.86 (.84–.87)

In this cohort, 723 (21.3%) patients met criteria for urinary tract infection (UTI), and 2669 (78.7%) did not have a UTI.

Abbreviations: AUROC, area under the receiver operating characteristic curve; CI, confidence interval; hpf, high-power field; LE, leukocyte esterase; NPV, negative predictive value; WBC, white blood cell.

DISCUSSION

In this cohort study of 3392 patients who received urine tests for suspicion of UTI, all UA parameters, alone or in combination, had poor PPV for the diagnosis of UTI. However, absence of urinalysis parameters (eg, pyuria) had a high NPV for ruling out UTI. Additionally, both NPV and PPV of all UA parameters were low in older women, likely due to contamination or colonization [11]. Most importantly, combined urinalysis parameters (pyuria or nitrite) performed better than pyuria alone for ruling out UTI, especially in men and in patients <65 years of age. If hospital laboratories leveraged combined UA criteria (1+ leukocyte esterase or nitrite OR pyuria 10 WBCs/hpf or nitrite) for their NPV, almost half of unnecessary urine culture orders can be avoided.

Our study also highlights the poor performance of commonly used pyuria thresholds (≥5, ≥10, ≥20 WBCs) in reflex urine culture protocols [2–4]. One prior study showed that higher degree of pyuria should be considered when evaluating older women for UTI [5]. However, our study showed that sensitivity of pyuria in diagnosing UTI decreased with increasing levels of pyuria. These differences can likely be explained by our patient population (hospitalized patients) and evaluating UA performance using real-world experiences with urine culture ordering and collection. This is an important finding as increasing levels of pyuria drive inappropriate antimicrobial prescribing, even in asymptomatic hospitalized inpatients [1].

Hence, a concerted effort should be made to reduce reliance on positive UA parameters as the sole criteria to order urine cultures. This can be done by limiting the use of reflex urine culture protocols to symptomatic patients and developing clinical decision support tools to avoid urine testing in asymptomatic patients. Another alternative would be to use conditional urine cultures, where both UA and urine culture are simultaneously ordered, but the urine culture is canceled based on UA criteria. Second, even when leveraged for their NPV, UA parameters vary based on the patient characteristics: male versus female patients, symptomatic versus asymptomatic patients, or older versus younger patients. Hence, reflex urine cultures or clinical decision support tools should incorporate appropriate exclusion criteria based both on patient population (eg, neutropenic patients) and markers of contamination (eg, squamous cells) [6].

We acknowledge the inherent limitations of our retrospective design, chart review process, and generalizability as we examined data from hospitals in the southeastern United States. We also did not include pediatric, catheterized, or outpatient clinic populations. In the absence of patient-specific antibiotic use data, we could not exclude patients who received prior antibiotics. Additionally, our definition of UTI was based on expert panel discussions, as there is no consistent definition across infectious disease and urologic societies [12, 13].

Most guidelines and antibiotic stewardship interventions focus on urine cultures, but UA is an important precursor test that needs to be targeted for diagnostic stewardship [1]. Additionally, UA performance varies across patient populations and laboratories, which highlights the need for site-specific assessment. We need to educate clinicians about the poor PPV of positive UA parameters to decrease reliance on UA for diagnosing UTIs, especially in older adults. Future reflex urine culture workflows and urine culture stewardship interventions should leverage UA for its NPV and prioritize populations where the absence of pyuria indicates a low likelihood of UTI [6].

Supplementary Data

Supplementary materials are available at Clinical Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.

Supplementary Material

ciae230_Supplementary_Data

Contributor Information

Sonali D Advani, Division of Infectious Diseases, Department of Medicine, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University School of Medicine.

Rebecca North, Duke Center for the Study of Aging and Human Development, Durham, North Carolina.

Nicholas A Turner, Division of Infectious Diseases, Department of Medicine, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University School of Medicine.

Sahra Ahmadi, Department of Medicine, WellStar Health System, Atlanta, Georgia.

Julia Denniss, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Adero Francis, Department of Medicine, WellStar Health System, Atlanta, Georgia.

Rachel Johnson, Department of Medicine, WellStar Health System, Atlanta, Georgia.

Anum Hasan, Department of Medicine, Sovah Medical Center, Danville, Virginia.

Faryal Mirza, Department of Medicine, Sovah Medical Center, Danville, Virginia.

Sarah Pardue, Department of Medicine, Sovah Medical Center, Danville, Virginia.

Meghana Rao, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Yasmin Rosshandler, Department of Medicine, WellStar Health System, Atlanta, Georgia.

Helen Tang, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Kenneth E Schmader, Division of Geriatrics, Department of Medicine, Duke and Durham Veterans Affairs Medical Center, Durham, North Carolina.

Deverick J Anderson, Division of Infectious Diseases, Department of Medicine, Duke Center for Antimicrobial Stewardship and Infection Prevention, Duke University School of Medicine.

Notes

Financial support. This work was supported by the Centers for Disease Control and Prevention (grant number 5U54CK000616-02 to D. J. A. and S. D. A.). Chart reviewers and R. N. were supported by the National Institute of Diabetes and Digestive and Kidney Diseases to Duke (grant number K12DK100024)

References

  • 1. Gupta K, O’Brien W, Gallegos-Salazar J, Strymish J, Branch-Elliman W. How testing drives treatment in asymptomatic patients: level of pyuria directly predicts probability of antimicrobial prescribing. Clin Infect Dis 2020; 71:614–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ling D, Seidelman J, Dodds-Ashley E, et al. Navigating reflex urine culture practices in community hospitals: need for a validated approach. Am J Infect Control 2020; 48:1549–51. [DOI] [PubMed] [Google Scholar]
  • 3. Sullivan KV, Morgan DJ, Leekha S. Use of diagnostic stewardship practices to improve urine culturing among SHEA Research Network hospitals. Infect Control Hosp Epidemiol 2019; 40:228–31. [DOI] [PubMed] [Google Scholar]
  • 4. Humphries RM, Dien Bard J. Point-counterpoint: reflex cultures reduce laboratory workload and improve antimicrobial stewardship in patients suspected of having urinary tract infections. J Clin Microbiol 2016; 54:254–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bilsen MP, Aantjes MJ, van Andel E, et al. Current pyuria cutoffs promote inappropriate urinary tract infection diagnosis in older women. Clin Infect Dis 2023; 76:2070–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Advani SD, Turner NA, Schmader KE, et al. Optimizing reflex urine cultures: using a population-specific approach to diagnostic stewardship. Infect Control Hosp Epidemiol 2023; 44:206–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Keller SC, Feldman L, Smith J, Pahwa A, Cosgrove SE, Chida N. The use of clinical decision support in reducing diagnosis of and treatment of asymptomatic bacteriuria. J Hosp Med 2018; 13:392–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship—leveraging the laboratory to improve antimicrobial use. JAMA 2017; 318:607–8. [DOI] [PubMed] [Google Scholar]
  • 9. Vaughn VM, Gupta A, Petty LA, et al. A statewide quality initiative to reduce unnecessary antibiotic treatment of asymptomatic bacteriuria. JAMA Intern Med 2023; 183:933–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Advani SD, Turner NA, North R, et al. Proposing the “continuum of urinary tract infection (UTI)” for a nuanced approach to diagnosis and management of UTIs. J Urol 2024; 211:690–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Whelan P, Nelson A, Kim CJ, et al. Investigating risk factors for urine culture contamination in outpatient clinics: a new avenue for diagnostic stewardship. Antimicrob Steward Healthc Epidemiol 2022; 2:e29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Anger JT, Bixler BR, Holmes RS, Lee UJ, Santiago-Lastra Y, Selph SS. Updates to recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol 2022; 208:536–41. [DOI] [PubMed] [Google Scholar]
  • 13. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103–20. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ciae230_Supplementary_Data

Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES